Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06847685 · ClinicalTrials.gov registry record
Mechanisms of Uterine Fluid Absorption During Early Pregnancy ( ELF Study)
A clinical trial of Endometriosis and Endometrioma, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- 140
- Enrollment target
- 3
- Study locations
NCT06847685 is a study of Endometriosis and Endometrioma that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 140 participants, below the 261-participant average among 48 other Endometriosis trials with a reported enrollment target (46% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06847685, a study of Endometriosis and Endometrioma, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- 140 participants
- Enrollment target
- 3
- Study locations
Study Summary
The researchers are evaluating mechanisms of uterine fluid absorption during early pregnancy
Conditions Studied
Study Locations (3)
Georgia
- University of Georgia - Athens
Maryland
- Johns Hopkins Hospital - Baltimore
New Jersey
- Rutgers University - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2030-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06847685
The ClinicalTrials.gov registry entry for NCT06847685 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 48 other Endometriosis trials with a reported enrollment target (46% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Endometriosis appearing as the primary indexed condition, and to 0 interventions.
NCT06847685 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Georgia, Maryland, New Jersey.
Frequently Asked Questions
What is clinical trial NCT06847685 about?
NCT06847685 is a clinical study titled "Mechanisms of Uterine Fluid Absorption During Early Pregnancy ( ELF Study)". The researchers are evaluating mechanisms of uterine fluid absorption during early pregnancy
What is the current status of trial NCT06847685?
This trial is currently recruiting. The enrollment target is 140 participants. The study started on 2025-02-01. Estimated completion is 2030-02-01.
What conditions does trial NCT06847685 study?
This clinical trial studies the following conditions: Endometriosis, Endometrioma.
Who is sponsoring clinical trial NCT06847685?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06847685 being conducted?
This trial has 3 study locations across Georgia, Maryland, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometriosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Thromboxane Function in Women With Endometriosis
RECRUITING · Phase 4
-
Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
RECRUITING · NA
-
The Impact of Yoga on Endometriosis-Related Pain
RECRUITING · NA
-
Endometriosis and Microvascular Dysfunction: Role of Inflammation
RECRUITING · Early Phase 1
-
Physical Therapy After Endometriosis Excision
RECRUITING · NA
-
Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.